P. Rickenbacher

M. Pfisterer, S. Pedersen, J. Jensen, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

S. Hunt, R. Popp, H. Valantine, 1996, Transplantation.

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

J. Schroeder, P. Trindade, P. Oyer, 1996, Heart.

Expression of inducible nitric oxide synthase in human heart failure.

P. Tsao, J. Cooke, P. Trindade, 1996, Circulation.

Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography.

S. Hunt, H. Valantine, J. Schroeder, 1995, The American journal of cardiology.

Comparison of presentation, perception, and six-month outcome between women and men > or =75 years of age with angina pectoris.

M. Pfisterer, P. Buser, C. Schindler, 2003, The American journal of cardiology.

utpatient Rehabilitation in Patients With Coronary Artery nd Peripheral Arterial Occlusive Disease

M. Pfisterer, P. Rickenbacher, A. Hoffmann, 2008 .

Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins.

M. Nicholls, P. Rickenbacher, O. Bertel, 2000, The American journal of cardiology.

New Heart Failure Guidelines: Update for Primary Care.

P. Rickenbacher, 2017, Praxis.

Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF.

L. Tavazzi, R. Latini, S. Masson, 2016, Clinical chemistry.

Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial.

M. Pfisterer, J. Čelutkienė, V. V. van Empel, 2019, The American journal of medicine.

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life.

S. Hunt, H. Valantine, E. Stinson, 1997, European heart journal.

[Subjective tolerance to transesophageal echocardiography].

T. Lüscher, P. Rickenbacher, D. Burckhardt, 1994, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

H. Schächinger, R. Ritz, W. Zimmerli, 2000, Critical care medicine.

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

J. Schroeder, P. Trindade, G. Haywood, 1996, Journal of the American College of Cardiology.

'Torsades de pointes' in a patient with history of epilepsy"

P. Rickenbacher, S. Osswald, I. Keller, 2007 .

Tako-Tsubo-Kardiomyopathie: «transient left ventricular apical ballooning»

P. Rickenbacher, R. Handschin, N. Hess, 2004 .

TIME has come to have a closer look at the management of cardiovascular disease in the elderly.

M. Pfisterer, P. Rickenbacher, 2002, European heart journal.

Curing heart failure with cathether ablation

P. Rickenbacher, M. Kühne, M. Mutschelknauss, 2010 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Chest pain early after percutaneous coronary intervention: incidence and relation to ECG changes, cardiac enzymes and follow-up events.

M. Pfisterer, R. Ritz, M. Schüepp, 2001, The Journal of invasive cardiology.

Benefit of outpatient cardiac rehabilitation in under-represented patient subgroups.

M. Pfisterer, R. Jeger, P. Rickenbacher, 2007, Journal of rehabilitation medicine.

Pre‐clinical diabetic cardiomyopathy: prevalence, screening, and outcome

K. Berneis, P. Rickenbacher, H. Brunner-LaRocca, 2010, European journal of heart failure.

Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors.

A. Gratwohl, J. Passweg, C. Haberthür, 2001, Swiss medical weekly.

Long‐term prognosis of young patients after myocardial infarction in the thrombolytic era

M. Pfisterer, R. Ritz, P. Rickenbacher, 1997, Clinical cardiology.

End-of-life preferences of elderly patients with chronic heart failure.

M. Pfisterer, H. Brunner-La Rocca, O. Pfister, 2012, European heart journal.

Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

John Wikstrand, Johan Herlitz, Rainer Dietz, 2000 .

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

R Dietz, J Herlitz, J Vítovec, 2000, JAMA.

Follow-Up From TIME-CHF Versus Symptom-Guided Treatment in Elderly Patients With Heart Failure : Five-Year Guided − Long-Term Results of Intensified , N-Terminal-ProB-Type Natriuretic Peptide

P. Erne, F. Nietlispach, H. Rickli, 2014 .

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Patrick Hunziker, Christoph Kaiser, M. Pfisterer, 2006, Journal of the American College of Cardiology.

Why and how do elderly patients with heart failure die? Insights from the TIME‐CHF study

F. Follath, H. Brunner-La Rocca, P. Rickenbacher, 2012, European journal of heart failure.

Using the detailed database from The Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart

F. Follath, H. Brunner-La Rocca, P. Rickenbacher, 2012 .

N‐terminal pro brain natriuretic peptide‐guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF)

P. Erne, H. Brunner-La Rocca, H. Rickli, 2013, European journal of heart failure.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Peter Buser, Thomas Suter, M. Pfisterer, 2009, JAMA.

Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.

M. Pfisterer, P. Erne, P. Buser, 2003, JAMA.

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

M. Ohlow, R. Jeger, J. Wöhrle, 2018, Clinical cardiology.

Angiotensinergic Versus Nonangiotensinergic Hemodynamic Effects of Converting Enzyme Inhibition in Patients With Chronic Heart Failure: Assessment by Acute Renin and Converting Enzyme Inhibition

T. Meinertz, P. Rickenbacher, W. Kiowski, 1994, Circulation.

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.

P. Tsao, S. Hunt, R. Johns, 1996, Circulation.

Outpatient rehabilitation in patients with coronary artery and peripheral arterial occlusive disease.

M. Pfisterer, R. Jeger, P. Rickenbacher, 2008, Archives of physical medicine and rehabilitation.

Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).

M. Pfisterer, P. Buser, H. Brunner-La Rocca, 2006, American heart journal.

Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?

M. Pfisterer, H. Brunner-La Rocca, B. Kaufmann, 2018, European journal of internal medicine.

Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).

M. Pfisterer, P. Erne, H. Brunner-La Rocca, 2013, JACC. Heart failure.

Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

S. Hunt, H. Valantine, B. Brown, 1995, Circulation.

Unusual VDD-pacing.

P. Rickenbacher, S. Osswald, S. Kiencke, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.

Joël M. H. Karel, M. Pfisterer, N. Davarzani, 2017, Journal of cardiac failure.

University of Groningen Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients

P. Erne, H. Rickli, P. Rickenbacher, 2013 .

Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?

M. Pfisterer, F. Nietlispach, H. Brunner-La Rocca, 2013, Netherlands Heart Journal.

Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive, preventive, and personalized medicine

Joël M. H. Karel, Ralf Peeters, Nasser Davarzani, 2018, EPMA Journal.

Long-term outcome after heart transplantation for peripartum cardiomyopathy.

S. Hunt, P. Rickenbacher, M. Fowler, 1994, American heart journal.

Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.

F. Eberli, D. Conen, M. Pfisterer, 2015, Circulation.